Found 8 matching trials
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
PHASE2A Randomized Phase 2 double blind study which aims to determine the safety ...
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
PHASE2A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study...
Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults
PHASE3This study seeks to evaluate the safety, tolerability, and efficacy of topi...
Location
Austin Institute for Clinical Research, Inc.
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
PHASE4The objective of this research is to demonstrate superior anti-inflammatory...
Location
Dermatology Consulting Services, PLLC
Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams
N/AThe purpose of this study was to compare the relative vasoconstrictive effe...
Location
Multiple Locations
Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis
PHASE1Suppression Potential of Topically Applied IDP-118 Lotion and HP Monad Loti...
Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis
PHASE2The purpose of this study is to determine whether the investigational lotio...
Location
Therapeutics Clinical Research
Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
PHASE2Safety and Efficacy of IDP-118 Lotion to Ultravate® Cream, in the Treatment...